142 related articles for article (PubMed ID: 16059580)
1. [Ocular toxicity caused by chloroquine: case report].
Inada ET; Watanabe KP; Tanaka SG; Sakakisbara LA
Arq Bras Oftalmol; 2005; 68(3):407-9. PubMed ID: 16059580
[TBL] [Abstract][Full Text] [Related]
2. Chloroquine-induced bull's eye maculopathy.
Lai WW; Lam DS
Hong Kong Med J; 2005 Feb; 11(1):55-7. PubMed ID: 15687518
[TBL] [Abstract][Full Text] [Related]
3. [Ocular toxicity caused by tamoxifen: case report].
Inada ET; Watanabe KP; Tanaka SG; Sakakisbara LA
Arq Bras Oftalmol; 2005; 68(4):554-6. PubMed ID: 16322846
[TBL] [Abstract][Full Text] [Related]
4. [Chloroquine-induced bull's eye maculopathy without electrophysiologic changes].
Cursiefen C; Grunert U; Jünemann A
Klin Monbl Augenheilkd; 1997 Jun; 210(6):400-1. PubMed ID: 9333669
[TBL] [Abstract][Full Text] [Related]
5. [The ERG contribution in early diagnosis of chloroquine and hydroxychloroquine maculopathy].
Karkanová M; Matusková V; Vlková E; Dosková H; Uhmannová R
Cesk Slov Oftalmol; 2010 Apr; 66(2):62-6. PubMed ID: 20925239
[TBL] [Abstract][Full Text] [Related]
6. Macular sensitivity changes for detection of chloroquine toxicity in asymptomatic patient.
Angi M; Romano V; Valldeperas X; Romano F; Romano MR
Int Ophthalmol; 2010 Apr; 30(2):195-7. PubMed ID: 19165421
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic findings in chloroquine maculopathy.
Halfeld Furtado de Mendonça R; Maia OO; Yukihiko Takahashi W
Doc Ophthalmol; 2007 Sep; 115(2):117-9. PubMed ID: 17562091
[TBL] [Abstract][Full Text] [Related]
8. Macular toxicity after short-term hydroxychloroquine therapy.
Pasaoglu I; Onmez FE
Indian J Ophthalmol; 2019 Feb; 67(2):289-292. PubMed ID: 30672499
[TBL] [Abstract][Full Text] [Related]
9. Ophthaproblem. Chloroquine or hydroxychloroquine retinopathy.
Liu W; Sharma S
Can Fam Physician; 2005 May; 51(5):671, 679-80. PubMed ID: 15934269
[No Abstract] [Full Text] [Related]
10. Delayed progression of bull's eye maculopathy.
Jain S; Jain NG
BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28596207
[TBL] [Abstract][Full Text] [Related]
11. Severe visual loss secondary to retinal toxicity after intravenous use of bisphosphonate in an eye with known chloroquine maculopathy.
Bursztyn LL; Masri M; Sheidow TG
Retin Cases Brief Rep; 2014; 8(4):322-5. PubMed ID: 25372538
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine-induced bull's eye maculopathy in rheumatoid arthritis: related to disease duration?
Shinjo SK; Maia OO; Tizziani VA; Morita C; Kochen JA; Takahashi WY; Laurindo IM
Clin Rheumatol; 2007 Aug; 26(8):1248-53. PubMed ID: 17264974
[TBL] [Abstract][Full Text] [Related]
13. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Michaelides M; Stover NB; Francis PJ; Weleber RG
Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
[TBL] [Abstract][Full Text] [Related]
14. Ocular fundus manifestation of two patients following long-term chloroquine therapy: a case report.
Ma X; Yan L; He L; He D; Lu H
Diagn Pathol; 2010 Mar; 5():20. PubMed ID: 20346186
[TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography in a patient with chloroquine-induced maculopathy.
Korah S; Kuriakose T
Indian J Ophthalmol; 2008; 56(6):511-3. PubMed ID: 18974527
[TBL] [Abstract][Full Text] [Related]
16. Chloroquine keratopathy of rheumatoid arthritis patients detected by in vivo confocal microscopy.
Ma X; He L; He D; Xu J
Curr Eye Res; 2012 Apr; 37(4):293-9. PubMed ID: 22440160
[TBL] [Abstract][Full Text] [Related]
17. Case Report: Hydroxychloroquine Retinopathy.
Eldeeb M; Chan EW; Omar A
Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
[TBL] [Abstract][Full Text] [Related]
18. Spectral-domain optical coherence tomography as a screening technique for chloroquine and hydroxychloroquine retinal toxicity.
Kahn JB; Haberman ID; Reddy S
Ophthalmic Surg Lasers Imaging; 2011; 42(6):493-7. PubMed ID: 21830746
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological and SD-OCT findings in patients receiving chloroquine therapy in relation to cumulative dosage and duration of treatment.
Bertoli F; Šuštar M; Jarc Vidmar M; Perovšek D; Brecelj J; Markelj Š; Jaki Mekjavić P; Šuput D; Tomšič M; Isola M; Battistella C; Lanzetta P; Hawlina M
Doc Ophthalmol; 2020 Aug; 141(1):1-14. PubMed ID: 31927702
[TBL] [Abstract][Full Text] [Related]
20. Retinal disorders in northern Brazilian patients treated with chloroquine assessed by multifocal ERG.
Raster M; Horn F; Jünemann A; Rosa AA; Souza GS; Gomes BD; Lima MG; Silveira LC; Kremers J
Doc Ophthalmol; 2011 Apr; 122(2):77-86. PubMed ID: 21290166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
